Envestnet Asset Management’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding FBIO
OM
SAM
GCP
BCM
Envestnet Asset Management's FBIO Position: Q1 2026 in Review
Envestnet Asset Management sold out of Fortress Biotech (FBIO) in Q1 2026, closing a stake of 23,508 shares — an estimated $86K sold.
Envestnet Asset Management first reported a position in FBIO in Q3 2019 and held it in 13 quarters. The position peaked at $485K in Q4 2024. 52 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.
- Envestnet Asset Management reported no remaining Fortress Biotech position as of Q1 2026 after selling out during the quarter.
- Envestnet Asset Management sold 23,508 Fortress Biotech shares in Q1 2026, an estimated $86K.
- Envestnet Asset Management first reported a position in Fortress Biotech in Q3 2019 and held it in 13 quarters.
- Envestnet Asset Management's Fortress Biotech position peaked at $485K in Q4 2024.
- 52 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.
Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.